Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events pd l1 testing results lung cancer
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
… thought leadership from our experts, and receive periodic news and updates. Fill out the form below to sign up. By …
… achieve study objectives and can support interpretation of results and examination of potential biases so that you can be confident in using your results to make informed decisions. Survey Analyses Whether … software that accounts for the sample design so that the results accurately answer your research questions about the …
… limitations of the data, along with interpretation of the results. Q. Can you please give few tips to adapt GVD to … itself we consider the information from the early payer testing and generally only seek additional input from the … such as payer research, scientific advice, HTA submissions results, etc. to inform, guide the GVD Development and …
… After analyzing your data, a tabular display of results spanning multiple pages may not be the best medium … becomes critical. It can translate a profusion of results into a user-friendly display that highlights salient … create appropriate graphical displays that will make the results of your analyses clear, understandable, and ready to …
… services (e.g., patient support programs) Presentations of results from studies, including clinical studies of drugs or …
Surveys and Observational Studies Beyond the evidence standards set by traditional clinical trials, well-designed and implemented surveys and observational studies can help you, your patients, regulators, and prescribers understand the real-world use, …
… will be presented at the ESMO Congress 2023. Breast cancer specific survival (BCSS) in HR+/HER2- metastatic breast cancer (mBC) from 2010 to 2019. Brufsky A, Kwan ML, Sandin … of patients with metastatic castration-resistant prostate cancer. Morris MJ, Armstrong AJ, Chi K, de Bono J, Herrmann …
… Agency (EMA) and US Food and Drug Administration (FDA) for cancer treatment found that the agencies use different … hosted by study authors and based on PRO labeling of cancer treatment drugs, focuses on key differences between … sponsors face when including PRO-related endpoints in cancer clinical research? And how can these challenges be …
RTI-HS researcher to lead study that will seek perspectives of those affected by Alzheimer’s Share on: May 22, 2018 Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug development process. The Alzheimer’s …